| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab176310-100μg |
100μg |
现货  |
| |
| Ab176310-1mg |
1mg |
现货 |
| |
| Ab176310-5mg |
5mg |
现货 |
| |
| Ab176310-10mg |
10mg |
期货 |
|
| 产品名称 | Tisotumab (anti-F3) |
|---|---|
| 别名 | 替索妥单抗 | 替雷利珠单抗 | 替索单抗 | 替索单抗 (抗 F3) |
| 英文别名 | CD142 antibody | CD142 antigen antibody | Coagulation factor III (thromboplastin tissue factor) antibody | Coagulation factor III antibody | F3 antibody | FLJ17960 antibody | TF antibody | TF_HUMAN antibody | TFA antibody | Thromboplastin antibody | Tissu |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | F3 |
| 种属反应性 | 人(Human),食蟹猴(Cynomolgus monkey) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 27.1 kDa (Light Chain) & 51.7 kDa (Heavy Chain), under reducing conditions; 184.7 kDa, under non-reducing conditions. |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1418628-81-5 |
| 分子类型 | 抗体 |
Tisotumab (anti-F3) (Ab176310) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling F3 (red) with Tisotumab (anti-F3) (Ab176310). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Tisotumab (anti-F3) (Ab176310) - SEC
The purity of Tisotumab (anti-F3) (Ab176310) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ23F1101847 |
分析证书 | 25-09-09 | Ab176310 |
| ZJ23F1101848 |
分析证书 | 25-09-09 | Ab176310 |
| ZJ24F0911527 |
分析证书 | 24-09-30 | Ab176310 |
| ZJ24F0911526 |
分析证书 | 24-09-30 | Ab176310 |
| ZJ24F0911528 |
分析证书 | 24-09-30 | Ab176310 |
¥669.90
| 1. Choi-Sledeski YM, McGarry DG, Green DM, Mason HJ, Becker MR, Davis RS, Ewing WR, Dankulich WP, Manetta VE, Morris RL, Spada AP, Cheney DL, Brown KD, Colussi DJ, Chu V, Heran CL, Morgan SR, Bentley RG, Leadley RJ, Maignan S, Guilloteau JP, Dunwiddie CT, Pauls HW.. (1999) Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization.. J Med Chem, 42 (18): (3572-3587). [PMID:10479289] [10.1021/jm990041+] |
| 2. Parlow JJ, Case BL, Dice TA, Fenton RL, Hayes MJ, Jones DE, Neumann WL, Wood RS, Lachance RM, Girard TJ, Nicholson NS, Clare M, Stegeman RA, Stevens AM, Stallings WC, Kurumbail RG, South MS.. (2003) Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.. J Med Chem, 46 (19): (4050-4062). [PMID:12954058] [10.1021/jm030131l] |
| 3. Wang D, Girard TJ, Kasten TP, LaChance RM, Miller-Wideman MA, Durley RC.. (1998) Inhibitory activity of unsaturated fatty acids and anacardic acids toward soluble tissue factor-factor VIIa complex.. J Nat Prod, 61 (11): (1352-1355). [PMID:9834151] [10.1021/np980117p] |
| 4. Breij EC, de Goeij BE, Verploegen S, Schuurhuis DH, Amirkhosravi A, Francis J, Miller VB, Houtkamp M, Bleeker WK, Satijn D et al.. (2014) An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.. Cancer Res, 74 (4): (1214-26). [PMID:24371232] [10.1021/op500134e] |
| 5. Jianguo Wang,Shawn A Mahmud,Peter B Bitterman,Yuqing Huo,Arne Slungaard. (2007-08-07) Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes.. The Journal of biological chemistry, 282 ((39)): (28408-28418). [PMID:17675290] |
| 6. Young WB, Mordenti J, Torkelson S, Shrader WD, Kolesnikov A, Rai R, Liu L, Hu H, Leahy EM, Green MJ, Sprengeler PA, Katz BA, Yu C, Janc JW, Elrod KC, Marzec UM, Hanson SR.. (2006) Factor VIIa inhibitors: chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.. Bioorg Med Chem Lett, 16 (7): (2037-2041). [PMID:16412633] [10.1016/j.bmcl.2005.12.059] |
| 7. Steinmetzer T, Schweinitz A, Stürzebecher A, Dönnecke D, Uhland K, Schuster O, Steinmetzer P, Müller F, Friedrich R, Than ME, Bode W, Stürzebecher J.. (2006) Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.. J Med Chem, 49 (14): (4116-4126). [PMID:16821772] [10.1021/jm051272l] |
| 8. Pinto DJ, Orwat MJ, Quan ML, Han Q, Galemmo RA, Amparo E, Wells B, Ellis C, He MY, Alexander RS, Rossi KA, Smallwood A, Wong PC, Luettgen JM, Rendina AR, Knabb RM, Mersinger L, Kettner C, Bai S, He K, Wexler RR, Lam PY.. (2006) 1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.. Bioorg Med Chem Lett, 16 (15): (4141-4147). [PMID:16730984] [10.1016/j.bmcl.2006.02.069] |
| 9. Kotian PL, Krishnan R, Rowland S, El-Kattan Y, Saini SK, Upshaw R, Bantia S, Arnold S, Babu YS, Chand P.. (2009) Design, parallel synthesis, and crystal structures of biphenyl antithrombotics as selective inhibitors of tissue factor FVIIa complex. Part 1: Exploration of S2 pocket pharmacophores.. Bioorg Med Chem, 17 (11): (3934-3958). [PMID:19409795] [10.1016/j.bmc.2009.04.013] |
| 10. Zhang X, Glunz PW, Johnson JA, Jiang W, Jacutin-Porte S, Ladziata V, Zou Y, Phillips MS, Wurtz NR, Parkhurst B, Rendina AR, Harper TM, Cheney DL, Luettgen JM, Wong PC, Seiffert D, Wexler RR, Priestley ES.. (2016) Discovery of a Highly Potent, Selective, and Orally Bioavailable Macrocyclic Inhibitor of Blood Coagulation Factor VIIa-Tissue Factor Complex.. J Med Chem, 59 (15): (7125-7137). [PMID:27455395] [10.1021/acs.jmedchem.6b00469] |
| 11. Ladziata VU, Glunz PW, Zou Y, Zhang X, Jiang W, Jacutin-Porte S, Cheney DL, Wei A, Luettgen JM, Harper TM, Wong PC, Seiffert D, Wexler RR, Priestley ES.. (2016) Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitors.. Bioorg Med Chem Lett, 26 (20): (5051-5057). [PMID:27612545] [10.1016/j.bmcl.2016.08.088] |
| 12. Fischer PM.. (2018) Design of Small-Molecule Active-Site Inhibitors of the S1A Family Proteases as Procoagulant and Anticoagulant Drugs.. J Med Chem, 61 (9): (3799-3822). [PMID:29072911] [10.1021/acs.jmedchem.7b00772] |
| 13. Rogers, K S KS, Barton, C L CL, Benson, P A PA and Green, R A RA.. (1992) Effects of single-dose L-asparaginase on coagulation values in healthy dogs and dogs with lymphoma.. American journal of veterinary research, [PMID:1586032] |
| 14. Mackman, N N, Morrissey, J H JH, Fowler, B B and Edgington, T S TS.. (1989) Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade.. Biochemistry, (21): [PMID:2719931] |
| 15. Scarpati, E M EM and 6 more authors.. (1987) Human tissue factor: cDNA sequence and chromosome localization of the gene.. Biochemistry, (25): [PMID:2823875] |
| 16. Spicer, E K EK and 9 more authors.. (1987) Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.. Proceedings of the National Academy of Sciences of the United States of America, [PMID:3037536] |
| 17. Bach, R R, Konigsberg, W H WH and Nemerson, Y Y.. (1988) Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine.. Biochemistry, (14): [PMID:3166978] |
| 18. Morrissey, J H JH, Fakhrai, H H and Edgington, T S TS.. (1987) Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade.. Cell, (3): [PMID:3297348] |
| 19. Fisher, K L KL, Gorman, C M CM, Vehar, G A GA, O'Brien, D P DP and Lawn, R M RM.. (1987) Cloning and expression of human tissue factor cDNA.. Thrombosis research, (1): [PMID:3424286] |
| 20. Muller, Y A YA, Ultsch, M H MH, Kelley, R F RF and de Vos, A M AM.. (1994) Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.. Biochemistry, (13): [PMID:8086403] |
| 21. Banner, D W DW and 7 more authors.. (1996) The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.. Nature, (7): [PMID:8598903] |
| 22. Muller, Y A YA, Ultsch, M H MH and de Vos, A M AM.. (1996) The crystal structure of the extracellular domain of human tissue factor refined to 1.7 A resolution.. Journal of molecular biology, (16): [PMID:8609606] |
| 23. Zhang, E E, St Charles, R R and Tulinsky, A A.. (1999) Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.. Journal of molecular biology, (5): [PMID:9925787] |
| 24. Bogdanov, Vladimir Y VY and 5 more authors.. (2003) Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein.. Nature medicine, [PMID:12652293] |
| 25. Eisenreich, Andreas A and 7 more authors.. (2009) Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.. Circulation research, (13): [PMID:19168442] |
| 26. Nadir, Yona Y and 5 more authors.. (2010) Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII.. Haematologica, [PMID:20634491] |
| 27. Hong, David S and 20 more authors.. (2020) Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research, (15): [PMID:31796521] |
首页
400-620-6333
